Mealey's (June 20, 2022, 10:48 AM EDT) -- SAN FRANCISCO — A California federal judge on June 16 granted in part and denied in part a pharmaceutical manufacturer’s motion to dismiss claims that it misrepresented its 4% lidocaine patch as “Maximum Strength,” as the judge found the plaintiffs adequately alleged an injury but failed to “allege that they lack an adequate remedy at law” in their claim for equitable relief under California’s unfair competition law (UCL)....